Tenmizu FinTech

永笙-KY 4178

Listed · Biotechnology and medical care
Backtest

Sign up to add 永笙-KY to your watchlist

Sign up to use the watchlist, price alerts and backtests, and keep your personalised settings.

Continue to sign up or sign in

Already have an account? Sign in

15.5▼-0.45 (-2.82%)After close
Prev close
15.95
Volume (shares)
198,336
Data time
2026-11-11 13:30:00
Open
15.90
High
15.95
Low
15.35
Prev close
15.95
Volume (lots)
198
Turnover
0.03 億
P/E
—
Cash yield
—

Financial trends

Loading…

Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.

Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC

Loading…

Figures are shown as announced, with no scoring or rating.

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22024 Q42024 Q22023 Q4
Gross margin34.09%27.68%29.07%29.32%————
Operating margin-58.23%-63.85%-77.59%-74.44%————
Net margin-53.60%-41.43%-55.66%-50.39%————
ROE (TTM)-9.57%—-9.59%—-14.45%-14.77%——
ROA (TTM)-5.57%—-5.48%—-7.14%-7.64%——
EPS, quarter (TWD)-0.25-0.19-0.25-0.22————
EPS, TTM (TWD)-0.91—-0.92—-0.96-1.14—-2.21

No data.

Revenue in NT$100M; 12 months per page.

No data.

Amounts in NT$100M (per-share items in NT$).

No data.

Amounts in NT$100M (per-share items in NT$).

No data.

Amounts in NT$100M (per-share items in NT$).

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22024 Q42024 Q22023 Q4
Current ratio1,160.21%———————
Debt ratio40.68%45.73%43.73%43.31%43.10%42.12%60.10%58.56%
Equity ratio59.32%54.27%56.27%56.69%56.90%57.88%39.90%41.44%
Equity multiplier1.691.841.781.761.761.732.512.41

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22024 Q42024 Q22023 Q4
Asset turnover (TTM revenue / avg. assets)0.11—0.14—0.130.11—0.18
Equity turnover0.19—0.28—0.230.20—0.43

Source: MOPS. For reference only; not investment advice.